Gainers
• Hepion Pharmaceuticals, Inc. HEPA shares increased by 34.7% to $6.71 during Wednesday's pre-market session. The most recent rating by Brookline Capital, on November 22, is at Buy, with a price target of $12.00.
• Conatus Pharmaceuticals, Inc. CNAT shares moved upwards by 19.0% to $0.49.
• Miragen Therapeutics, Inc. MGEN shares surged 7.0% to $1.69. The most recent rating by Baird, on December 12, is at Neutral, with a price target of $1.00.
• Sorrento Therapeutics, Inc. SRNE shares surged 6.4% to $4.31.
• Inovio Pharmaceuticals, Inc. INO shares moved upwards by 4.8% to $4.57. The most recent rating by PiperJaffray, on January 03, is at Overweight, with a price target of $8.00.
Losers
• Denali Therapeutics, Inc. DNLI shares fell 4.5% to $23.72 during Wednesday's pre-market session. The most recent rating by Goldman Sachs, on January 27, is at Buy, with a price target of $37.00.
• Titan Pharmaceuticals, Inc. TTNP stock decreased by 3.5% to $0.28.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.